These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19400222)

  • 1. Synthesis of mannosylated glycopeptides as components for synthetic vaccines.
    Kowalczyk R; Brimble MA; Dunbar R
    Adv Exp Med Biol; 2009; 611():351-2. PubMed ID: 19400222
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of fluorescein-labelled O-mannosylated peptides as components for synthetic vaccines: comparison of two synthetic strategies.
    Brimble MA; Kowalczyk R; Harris PW; Dunbar PR; Muir VJ
    Org Biomol Chem; 2008 Jan; 6(1):112-21. PubMed ID: 18075655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic glycopeptides for the development of cancer vaccines.
    Liakatos A; Kunz H
    Curr Opin Mol Ther; 2007 Feb; 9(1):35-44. PubMed ID: 17330400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a glycopeptide vaccine conjugate for induction of antibodies recognizing O-mannosyl glycopeptides.
    Yu J; Westerlind U
    Chembiochem; 2014 May; 15(7):939-45. PubMed ID: 24753400
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Hogervorst TP; Li RJE; Marino L; Bruijns SCM; Meeuwenoord NJ; Filippov DV; Overkleeft HS; van der Marel GA; van Vliet SJ; van Kooyk Y; Codée JDC
    ACS Chem Biol; 2020 Mar; 15(3):728-739. PubMed ID: 32045202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic vaccines from tumor-associated glycopeptide antigens.
    Westerlind U; Kunz H
    Chimia (Aarau); 2011; 65(1-2):30-4. PubMed ID: 21469441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide.
    Supekar NT; Lakshminarayanan V; Capicciotti CJ; Sirohiwal A; Madsen CS; Wolfert MA; Cohen PA; Gendler SJ; Boons GJ
    Chembiochem; 2018 Jan; 19(2):121-125. PubMed ID: 29120508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
    Cai H; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
    Chemistry; 2011 May; 17(23):6396-406. PubMed ID: 21538615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral immune response.
    Dziadek S; Hobel A; Schmitt E; Kunz H
    Angew Chem Int Ed Engl; 2005 Nov; 44(46):7630-5. PubMed ID: 16247815
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthetic antitumor vaccines containing MUC1 glycopeptides with two immunodominant domains-induction of a strong immune response against breast tumor tissues.
    Gaidzik N; Kaiser A; Kowalczyk D; Westerlind U; Gerlitzki B; Sinn HP; Schmitt E; Kunz H
    Angew Chem Int Ed Engl; 2011 Oct; 50(42):9977-81. PubMed ID: 21910197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water-soluble polymers coupled with glycopeptide antigens and T-cell epitopes as potential antitumor vaccines.
    Nuhn L; Hartmann S; Palitzsch B; Gerlitzki B; Schmitt E; Zentel R; Kunz H
    Angew Chem Int Ed Engl; 2013 Sep; 52(40):10652-6. PubMed ID: 24038824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In pursuit of carbohydrate-based HIV vaccines, part 2: The total synthesis of high-mannose-type gp120 fragments--evaluation of strategies directed to maximal convergence.
    Geng X; Dudkin VY; Mandal M; Danishefsky SJ
    Angew Chem Int Ed Engl; 2004 May; 43(19):2562-5. PubMed ID: 15127453
    [No Abstract]   [Full Text] [Related]  

  • 13. Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide.
    Thompson P; Lakshminarayanan V; Supekar NT; Bradley JM; Cohen PA; Wolfert MA; Gendler SJ; Boons GJ
    Chem Commun (Camb); 2015 Jun; 51(50):10214-7. PubMed ID: 26022217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray Analysis of Antibodies Induced with Synthetic Antitumor Vaccines: Specificity against Diverse Mucin Core Structures.
    Pett C; Cai H; Liu J; Palitzsch B; Schorlemer M; Hartmann S; Stergiou N; Lu M; Kunz H; Schmitt E; Westerlind U
    Chemistry; 2017 Mar; 23(16):3875-3884. PubMed ID: 27957769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of on-resin convergent synthesis of N-linked glycopeptides containing a large high mannose N-linked oligosaccharide.
    Chen R; Tolbert TJ
    J Am Chem Soc; 2010 Mar; 132(9):3211-6. PubMed ID: 20158247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a high-mannose-type glycopeptide analog containing a glucose-asparagine linkage.
    Deras IL; Takegawa K; Kondo A; Kato I; Lee YC
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1763-6. PubMed ID: 9873430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fully synthetic vaccines consisting of tumor-associated MUC1 glycopeptides and a lipopeptide ligand of the Toll-like receptor 2.
    Kaiser A; Gaidzik N; Becker T; Menge C; Groh K; Cai H; Li YM; Gerlitzki B; Schmitt E; Kunz H
    Angew Chem Int Ed Engl; 2010 May; 49(21):3688-92. PubMed ID: 20449837
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthetic vaccines of tumor-associated glycopeptide antigens by immune-compatible thioether linkage to bovine serum albumin.
    Wittrock S; Becker T; Kunz H
    Angew Chem Int Ed Engl; 2007; 46(27):5226-30. PubMed ID: 17546719
    [No Abstract]   [Full Text] [Related]  

  • 19. Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycolipopeptide cancer vaccine.
    Renaudet O; BenMohamed L; Dasgupta G; Bettahi I; Dumy P
    ChemMedChem; 2008 May; 3(5):737-41. PubMed ID: 18205167
    [No Abstract]   [Full Text] [Related]  

  • 20. Fully synthetic self-adjuvanting thioether-conjugated glycopeptide-lipopeptide antitumor vaccines for the induction of complement-dependent cytotoxicity against tumor cells.
    Cai H; Sun ZY; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
    Chemistry; 2013 Feb; 19(6):1962-70. PubMed ID: 23280874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.